Aethlon Medical, Inc. (AEMD) NASDAQ
2.21
-0.2(-8.30%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.21
-0.2(-8.30%)
Currency In USD
Address
11555 Sorrento Valley Road
San Diego, CA 92121
United States of America (the)
Phone
619 941 0360
Sector
Healthcare
Industry
Medical - Devices
Employees
14
First IPO Date
March 04, 1999
| Name | Title | Pay | Year Born |
| James Frakes | Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary & Director | 500,000 | 1957 |
| Steven LaRosa | Chief Medical Officer | 480,000 | 1968 |
| Michele Bombardiere | Vice President & Controller | 0 | N/A |
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.